Community Academic Profiles–

Mark Hlatky, MD

Back to Profile

Publication Details

  • Repeat revascularization is a faulty end point for clinical trials.

    Kazi DS, Hlatky MA. Circ Cardiovasc Qual Outcomes. 2012; 5 (3): 249-50

    PubMedID: 22592752

Stanford Medicine Resources:

Footer Links: